HomeSPRY • NASDAQ
ARS Pharmaceuticals Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 32.50M | 1,471.62% |
Operating expense | 76.84M | 234.51% |
Net income | -51.15M | -167.41% |
Net profit margin | -157.38 | 82.99% |
Earnings per share | -0.52 | -160.00% |
EBITDA | -52.80M | -143.02% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 288.21M | 40.72% |
Total assets | 372.80M | 71.32% |
Total liabilities | 225.15M | 1,254.44% |
Total equity | 147.66M | — |
Shares outstanding | 197.70M | — |
Price to book | 4.76 | — |
Return on assets | -38.75% | — |
Return on capital | -45.59% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -51.15M | -167.41% |
Cash from operations | -47.05M | -225.20% |
Cash from investing | -44.98M | -367.46% |
Cash from financing | 100.05M | 14,612.50% |
Net change in cash | 8.02M | 164.50% |
Free cash flow | -31.43M | -1,366.11% |
Previous close
$7.09
Day range
$6.95 - $7.40
Year range
$6.95 - $18.89
Market cap
701.33M USD
Avg Volume
2.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
165
